Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: a phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788.
about
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibodyMultitarget inhibitors derived from crosstalk mechanism involving VEGFR2.Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cellsAnalysis of Pogostemon cablin from pharmaceutical research to market performances.Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer.Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysis.
P2860
Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: a phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@ast
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@en
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@nl
type
label
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@ast
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@en
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@nl
prefLabel
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@ast
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@en
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@nl
P2093
P1476
Using pharmacokinetic and phar ...... sine kinase inhibitor, AEE788.
@en
P2093
Alain C Mita
Allan van Oosterom
Chris H Takimoto
Christie Low
Clifford DiLea
Erika Martinelli
Frederico Rojo
Herlinde Dumez
Jerry Huang
P304
P356
10.1158/1078-0432.CCR-12-1499
P407
P577
2012-09-26T00:00:00Z